Hui et al. discovered that inhibiting VEGFR2 promotes the expression of miR-3200-3p in tumor cell-secreted sEVs, leading to regulatory T-cell (Treg) aging in the TME and inhibiting subcutaneous tumor growth (Hui et al., 2024). This evidence concerns the gene KDR and neoplasm.